These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8024198)

  • 41. Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia.
    Leopold LH; Shore SK; Reddy EP
    Leuk Lymphoma; 1996 Aug; 22(5-6):365-73. PubMed ID: 8882949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
    Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
    Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-Ha-ras transfection and expression of MDR-related genes in MCF-10A human breast cell line.
    Di Simone D; Galimberti S; Basolo F; Ciardiello F; Petrini M; Scheper RJ
    Anticancer Res; 1997; 17(5A):3587-92. PubMed ID: 9413207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1.
    Davies BR; Davies MP; Gibbs FE; Barraclough R; Rudland PS
    Oncogene; 1993 Apr; 8(4):999-1008. PubMed ID: 8455951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
    Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
    Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ras oncoproteins transfer from melanoma cells to T cells and modulate their effector functions.
    Vernitsky H; Rechavi O; Rainy N; Besser MJ; Nagar M; Schachter J; Lerenthal Y; Ehrlich M; Kloog Y; Goldstein I
    J Immunol; 2012 Nov; 189(9):4361-70. PubMed ID: 23028055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector.
    Gibson SA; Pellenz C; Hutchison RE; Davey FR; Shillitoe EJ
    Clin Cancer Res; 2000 Jan; 6(1):213-22. PubMed ID: 10656452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
    Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
    Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of Ki-ras ribozyme activity by RNA binding protein, NCp7, in vitro and in pancreatic tumor cell line, capan 1.
    Moelling K; Mueller G; Dannull J; Reuss C; Beimling P; Bartz C; Wiedenmann B; Yoon K; Surovoy A; Jung G
    Ann N Y Acad Sci; 1994 Sep; 733():113-21. PubMed ID: 7978859
    [No Abstract]   [Full Text] [Related]  

  • 52. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
    Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
    Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
    Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta.
    Shellman YG; Chapman JT; Fujita M; Norris DA; Maxwell IH
    J Invest Dermatol; 2000 Jun; 114(6):1200-4. PubMed ID: 10844567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
    Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
    Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro cell transformation by ras oncogenes.
    Spandidos DA; Lang JC
    Crit Rev Oncog; 1989; 1(2):195-209. PubMed ID: 2488130
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 59. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
    Kowalski P; Stein U; Scheffer GL; Lage H
    Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.
    Tokunaga T; Tsuchida T; Kijima H; Okamoto K; Oshika Y; Sawa N; Ohnishi Y; Yamazaki H; Miura S; Ueyama Y; Nakamura M
    Br J Cancer; 2000 Sep; 83(6):833-9. PubMed ID: 10952790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.